Repligen Corporation
RGEN
$143.99
-$11.72-7.52%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 633.51M | 619.83M | 620.16M | 632.36M | 652.50M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 633.51M | 619.83M | 620.16M | 632.36M | 652.50M |
Cost of Revenue | 308.99M | 315.02M | 317.52M | 323.54M | 333.78M |
Gross Profit | 324.52M | 304.82M | 302.64M | 308.83M | 318.73M |
SG&A Expenses | 257.55M | 237.93M | 221.70M | 216.89M | 212.93M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 607.82M | 595.05M | 580.75M | 583.03M | 590.22M |
Operating Income | 25.69M | 24.78M | 39.41M | 49.33M | 62.29M |
Income Before Tax | 13.44M | 25.97M | 41.85M | 56.71M | 107.83M |
Income Tax Expenses | 21.53M | 16.49M | 18.29M | 21.11M | 7.05M |
Earnings from Continuing Operations | -8.10 | 9.48 | 23.56 | 35.60 | 100.78 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -8.10M | 9.48M | 23.56M | 35.60M | 100.78M |
EBIT | 25.69M | 24.78M | 39.41M | 49.33M | 62.29M |
EBITDA | 94.24M | 91.93M | 105.69M | 114.07M | 124.15M |
EPS Basic | -0.15 | 0.17 | 0.42 | 0.64 | 1.81 |
Normalized Basic EPS | 0.45 | 0.44 | 0.63 | 0.80 | 0.94 |
EPS Diluted | -0.15 | 0.16 | 0.41 | 0.63 | 1.77 |
Normalized Diluted EPS | 0.45 | 0.44 | 0.62 | 0.78 | 0.91 |
Average Basic Shares Outstanding | 223.50M | 223.26M | 223.08M | 222.88M | 222.60M |
Average Diluted Shares Outstanding | 224.79M | 225.72M | 226.14M | 226.66M | 227.95M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |